Cardiac valvulopathy.
Schachter
Michael
M
Department of Clinical Pharmacology, Imperial College School of Medicine, St Mary's Hospital, London W2 1NY.
D000978:Antiparkinson Agents / Q000009:adverse effects*; D018618:Echocardiography, Doppler, Color; D004878:Ergotamine / Q000009:adverse effects; D005277:Fenfluramine / Q000009:adverse effects; D006349:Heart Valve Diseases / Q000139:chemically induced* / Q000000981:diagnostic imaging; D006801:Humans; D018490:Serotonin Agents / Q000009:adverse effects
D000978:Antiparkinson Agents; D018490:Serotonin Agents; D005277:Fenfluramine; D004878:Ergotamine